Published • loading... • Updated
First patient joins randomised trial comparing TTVR systems
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
First patient joins randomised trial comparing TTVR systems
Topaz TRiCares has announced that the first patient has been enrolled and treated in the TRICURE US IDE pivotal study, evaluating Topaz, its transcatheter tricuspid valve replacement (TTVR) system. This enrolment marks the first randomised controlled study to actively enrol patients in a head-to-head comparison of an investigational TTVR system versus the commercially available Evoque TTVR system (Edwards Lifesciences). The US pivotal study init…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
